SERPINC1 and type 2 diabetes mellitus: Similarly, the activity of PC [49.25 U/ml (42.22–118.76) vs 40.64 U/ml (32.42–42.96) respectively, p = 0.002] (Fig 5D), PS [276.71 U/ml (248.52–577.36) vs 228.0 U/ml (198.97–259.30) respectively, p = 0.002] (Fig 5E) and AT III [200.84 U/ml (180.39–418.41) vs 168.13 U/ml (139.79–192.10) respectively, p = 0.004] (Fig 5F) were significantly increased among well-managed T2DM patients using statins compared to well-managed T2DM patients not on statins.